Francis Johnson

490 total citations
9 papers, 408 citations indexed

About

Francis Johnson is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Francis Johnson has authored 9 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Francis Johnson's work include Cancer therapeutics and mechanisms (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Environmental Toxicology and Ecotoxicology (1 paper). Francis Johnson is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Environmental Toxicology and Ecotoxicology (1 paper). Francis Johnson collaborates with scholars based in United States and Japan. Francis Johnson's co-authors include John S. Kovach, Jeffrey Chiang, Zhengping Zhuang, Jie Lu, Russell R. Lonser, Richard J. Hodes, Donald Richards, Gang Xie, Aaron S. Mansfield and Nengtai Ouyang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Clinical Cancer Research.

In The Last Decade

Francis Johnson

9 papers receiving 405 citations

Peers

Francis Johnson

MB

ONCOL

CR

PHARM

EC

Fumitaka Katoh France

Jeanette Seiler Germany

Thomas T. Tibbitts United States

Jennifer M. Finan United States

Yoshito Nakanishi Japan

Yu‐Wei Chang Taiwan

Julie Hall United States

Scott W. Blume United States

Frédéric Elustondo United Kingdom

Yangfei Xing China

Fumitaka Katoh France

Francis Johnson

524 ×2.2

MB

96 ×0.8

ONCOL

76 ×1.3

CR

16 ×0.3

PHARM

20 ×0.5

EC

Citations per year, relative to Francis Johnson Francis Johnson (= 1×) peers Fumitaka Katoh

Countries citing papers authored by Francis Johnson

Since Specialization

Citations

This map shows the geographic impact of Francis Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis Johnson more than expected).

Fields of papers citing papers by Francis Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis Johnson. The network helps show where Francis Johnson may publish in the future.

Co-authorship network of co-authors of Francis Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Francis Johnson. A scholar is included among the top collaborators of Francis Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis Johnson. Francis Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Chung, Vincent, Aaron S. Mansfield, Fadi Braiteh, et al.. (2016). Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial. Clinical Cancer Research. 23(13). 3277–3284. 91 indexed citations

2.

Huang, Liqun, Nengtai Ouyang, Yu Sun, et al.. (2010). The novel phospho‐non‐steroidal anti‐inflammatory drugs, OXT‐328, MDC‐22 and MDC‐917, inhibit adjuvant‐induced arthritis in rats. British Journal of Pharmacology. 162(7). 1521–1533. 48 indexed citations

3.

Mackenzie, Gerardo G., Yu Sun, Liqun Huang, et al.. (2010). Phospho-Sulindac (OXT-328), a Novel Sulindac Derivative, Is Safe and Effective in Colon Cancer Prevention in Mice. Gastroenterology. 139(4). 1320–1332. 51 indexed citations

4.

Lu, Jie, John S. Kovach, Francis Johnson, et al.. (2009). Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms. Proceedings of the National Academy of Sciences. 106(28). 11697–11702. 135 indexed citations

5.

Lu, Jie, Barbara Ikejiri, Stephanie Kim, et al.. (2008). LB-1, an inhibitor of serine-threonine protein phosphatase PP2A, suppresses the growth of glioblastoma cells in vitro and in vivo. 68. 5693–5693. 1 indexed citations

6.

Gelmi, Maria Luisa, Donato Pocar, Sara Pellegrino, et al.. (2006). 3-Demethoxy-3-glycosylaminothiocolchicines: Synthesis of a New Class of Putative Muscle Relaxant Compounds. Journal of Medicinal Chemistry. 49(18). 5571–5577. 7 indexed citations

7.

Johnson, Francis, et al.. (2000). Structure of an 11-mer DNA Duplex Containing the Carbocyclic Nucleotide Analog: 2′-Deoxyaristeromycin. Journal of Biomolecular Structure and Dynamics. 17(6). 981–991. 10 indexed citations

8.

Deamer-Melia, Nora J., et al.. (1999). Reporter gene assay for fish-killing activity produced by Pfiesteria piscicida.. Environmental Health Perspectives. 107(9). 711–714. 52 indexed citations

9.

Murray, William V., et al.. (1984). Steroids. 2. Synthesis of C-18 functionalized steroids via the Smith-Hughes route. Journal of Medicinal Chemistry. 27(9). 1131–1137. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact